Cargando…
FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cambridge University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225256/ https://www.ncbi.nlm.nih.gov/pubmed/37251002 http://dx.doi.org/10.1017/cts.2023.515 |
| _version_ | 1785050361630818304 |
|---|---|
| author | Russell, Elizabeth S. Aubrun, Elodie Moga, Daniela C. Guedes, Sandra Camelo Castillo, Wendy Hardy, Janet R. Cole, J. Alexander Jagun, Oladayo |
| author_facet | Russell, Elizabeth S. Aubrun, Elodie Moga, Daniela C. Guedes, Sandra Camelo Castillo, Wendy Hardy, Janet R. Cole, J. Alexander Jagun, Oladayo |
| author_sort | Russell, Elizabeth S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10225256 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Cambridge University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102252562023-05-29 FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology Russell, Elizabeth S. Aubrun, Elodie Moga, Daniela C. Guedes, Sandra Camelo Castillo, Wendy Hardy, Janet R. Cole, J. Alexander Jagun, Oladayo J Clin Transl Sci Perspective Cambridge University Press 2023-05-02 /pmc/articles/PMC10225256/ /pubmed/37251002 http://dx.doi.org/10.1017/cts.2023.515 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. |
| spellingShingle | Perspective Russell, Elizabeth S. Aubrun, Elodie Moga, Daniela C. Guedes, Sandra Camelo Castillo, Wendy Hardy, Janet R. Cole, J. Alexander Jagun, Oladayo FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology |
| title | FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology |
| title_full | FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology |
| title_fullStr | FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology |
| title_full_unstemmed | FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology |
| title_short | FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology |
| title_sort | fda draft guidance to improve clinical trial diversity: opportunities for pharmacoepidemiology |
| topic | Perspective |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225256/ https://www.ncbi.nlm.nih.gov/pubmed/37251002 http://dx.doi.org/10.1017/cts.2023.515 |
| work_keys_str_mv | AT russellelizabeths fdadraftguidancetoimproveclinicaltrialdiversityopportunitiesforpharmacoepidemiology AT aubrunelodie fdadraftguidancetoimproveclinicaltrialdiversityopportunitiesforpharmacoepidemiology AT mogadanielac fdadraftguidancetoimproveclinicaltrialdiversityopportunitiesforpharmacoepidemiology AT guedessandra fdadraftguidancetoimproveclinicaltrialdiversityopportunitiesforpharmacoepidemiology AT camelocastillowendy fdadraftguidancetoimproveclinicaltrialdiversityopportunitiesforpharmacoepidemiology AT hardyjanetr fdadraftguidancetoimproveclinicaltrialdiversityopportunitiesforpharmacoepidemiology AT colejalexander fdadraftguidancetoimproveclinicaltrialdiversityopportunitiesforpharmacoepidemiology AT jagunoladayo fdadraftguidancetoimproveclinicaltrialdiversityopportunitiesforpharmacoepidemiology |